BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 17727124)

  • 21. Folate fortification and supplementation--are we there yet?
    Bar-Oz B; Koren G; Nguyen P; Kapur BM
    Reprod Toxicol; 2008 Aug; 25(4):408-12. PubMed ID: 18550330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Folic Acid Fortified Flour for Prevention of Neural Tube Defects in a High Risk Region.
    Wang H; De Steur H; Chen G; Zhang X; Pei L; Gellynck X; Zheng X
    Nutrients; 2016 Mar; 8(3):152. PubMed ID: 27005659
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutritional interpretation of folic acid interventions.
    Dary O
    Nutr Rev; 2009 Apr; 67(4):235-44. PubMed ID: 19335717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Social and ethnic differences in folic acid use preconception and during early pregnancy in the UK: effect on maternal folate status.
    Brough L; Rees GA; Crawford MA; Dorman EK
    J Hum Nutr Diet; 2009 Apr; 22(2):100-7. PubMed ID: 19226351
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dietary folate intake, use of folate supplements, lifestyle factors, and serum folate levels among pregnant women in Tokyo, Japan.
    Matsuzaki M; Haruna M; Ota E; Sasaki S; Nagai Y; Murashima S
    J Obstet Gynaecol Res; 2008 Dec; 34(6):971-9. PubMed ID: 19012695
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Periconceptional folic acid supplementation: a new indication for therapeutic drug monitoring.
    Tam C; McKenna K; Goh YI; Klieger-Grossman C; O'Connor DL; Einarson A; Koren G
    Ther Drug Monit; 2009 Jun; 31(3):319-26. PubMed ID: 19349928
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Folic acid deficiency and its association with neural tube defects in northern Mexico].
    Rodríguez-Morán M; Guerrero-Romero JF; Parra-Quezada M; Segura-Pineda MJ; Levario-Carrillo M; Sotelo-Ham EI
    Salud Publica Mex; 1998; 40(6):474-80. PubMed ID: 9927882
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Should folic acid fortification be mandatory in Israel?
    Hacohen Y; Lerman-Sagie T
    Isr Med Assoc J; 2006 Sep; 8(9):649-50. PubMed ID: 17058420
    [No Abstract]   [Full Text] [Related]  

  • 29. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid.
    Heseker HB; Mason JB; Selhub J; Rosenberg IH; Jacques PF
    Br J Nutr; 2009 Jul; 102(2):173-80. PubMed ID: 19079944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothesis: folate-responsive neural tube defects and neurocristopathies.
    Antony AC; Hansen DK
    Teratology; 2000 Jul; 62(1):42-50. PubMed ID: 10861632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum copper and zinc levels in mothers and cord blood of their newborn infants with neural tube defects: a case-control study.
    Zeyrek D; Soran M; Cakmak A; Kocyigit A; Iscan A
    Indian Pediatr; 2009 Aug; 46(8):675-80. PubMed ID: 19430086
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Fortification of food with folic acid diminishes the number of neural tube defects].
    Brouwer IA
    Ned Tijdschr Geneeskd; 2008 Jan; 152(4):185-6. PubMed ID: 18320941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Maternal vitamin B12 and the risk of fetal neural tube defects in Egyptian patients.
    Gaber KR; Farag MK; Soliman SE; El-Bassyouni HT; El-Kamah G
    Clin Lab; 2007; 53(1-2):69-75. PubMed ID: 17323828
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Folic acid supplements to prevent neural tube defects: trends in East of Ireland 1996-2002.
    Ward M; Hutton J; Mc Donnell R; Bachir N; Scallan E; O'Leary M; Hoey J; Doyle A; Delany V; Sayers G
    Ir Med J; 2004 Oct; 97(9):274-6. PubMed ID: 15568585
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Folic acid: are current fortification levels adequate?
    Neuhouser ML; Beresford SA
    Nutrition; 2001 Oct; 17(10):868-72. PubMed ID: 11684394
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence and predictors of periconceptional folic acid uptake--prospective cohort study in an Irish urban obstetric population.
    McGuire M; Cleary B; Sahm L; Murphy DJ
    Hum Reprod; 2010 Feb; 25(2):535-43. PubMed ID: 19910320
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary prevention of neural tube defects with folate in Western Australia: the value of the Western Australian Birth Defects Registry.
    Bower C
    Congenit Anom (Kyoto); 2006 Jun; 46(2):118-21. PubMed ID: 16732771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maternal and fetal serum and red blood cell folate and vitamin B12 concentrations in pregnancies affected by neural tube defects.
    Thorand B; Pietrzik K; Prinz-Langenohl R; Hages M; Holzgreve W
    Z Geburtshilfe Neonatol; 1996; 200(5):176-80. PubMed ID: 8950836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospitalizations of newborns with folate-sensitive birth defects before and after fortification of foods with folic acid.
    Robbins JM; Tilford JM; Bird TM; Cleves MA; Reading JA; Hobbs CA
    Pediatrics; 2006 Sep; 118(3):906-15. PubMed ID: 16950980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Justifying the "Folate trap" in folic acid fortification programs.
    Mahajan NN; Mahajan KN; Soni RN; Gaikwad NL
    J Perinat Med; 2007; 35(3):241-2. PubMed ID: 17480154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.